PrEP and PEP Guidelines-Zambia
LEN in PBFW (pg. 25); Annex 1:Managing PrEP Side Effects for Pregnant and Breastfeeding Clients (not LEN specific); Annex 2: Deciding Whether to Pause or Stop PrEP Use for Pregnant and Breastfeeding Women (not LEN specific)
Resource Details
- Resource Category
- Lenacapavir (LEN), Policy & Guidelines
- Document Type
- Guidelines
- PrEP Modality
- Cabotegravir Long-Acting (CAB-LA), Lenacapavir (LEN), Oral PrEP
- Year
- 2025
- Source
- Zambia MOH
More Resources
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
HIV Prevention Ambassador Training Package and Toolkit
Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection
National Guidelines for the Management of HIV and AIDS
A Guiding Document on Differentiated Service Models for HIV/AIDS in Mozambique
No results found.